Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07580937 · ClinicalTrials.gov registry record
Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 198
- Enrollment target
NCT07580937 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 198 participants.
The verdict
NCT07580937 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 198 participants
- Enrollment target
Study Summary
The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics, procedural details, management of post-procedure anticoagulation, and clinical outcomes.
Interventions
- OTHER Data collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2022-03-08 |
| Est. Completion | 2026-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07580937
The ClinicalTrials.gov registry entry for NCT07580937 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Data collection is the first listed.
NCT07580937 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07580937 about?
NCT07580937 is a clinical study titled "Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients". The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics,...
What is the current status of trial NCT07580937?
This trial is currently completed. The enrollment target is 198 participants. The study started on 2022-03-08. Estimated completion is 2026-03-30.
What interventions are being tested in trial NCT07580937?
The interventions under investigation include: Data collection (OTHER).
Who is sponsoring clinical trial NCT07580937?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.